Process signatures in glatiramer acetate synthesis: structural and functional relationships.
Ontology highlight
ABSTRACT: Glatiramer Acetate (GA) is an immunomodulatory medicine approved for the treatment of multiple sclerosis, whose mechanisms of action are yet to be fully elucidated. GA is comprised of a complex mixture of polypeptides with different amino acid sequences and structures. The lack of sensible information about physicochemical characteristics of GA has contributed to its comprehensiveness complexity. Consequently, an unambiguous determination of distinctive attributes that define GA is of highest relevance towards dissecting its identity. Herein we conducted a study of characteristic GA heterogeneities throughout its manufacturing process (process signatures), revealing a strong impact of critical process parameters (CPPs) on the reactivity of amino acid precursors; reaction initiation and pol
SUBMITTER: Campos-Garcia VR
PROVIDER: S-EPMC5608765 | biostudies-literature | 2017 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA